Indaptus Therapeutics
INDP | NASDAQ
$3.45
+$0.28 (+8.83%)
At close: Nov 16, 2026, 4:00 PM ET
$3.45
$0.00 (0.00%)
After-hours:
Nov 16, 2026, 7:34 PM ET
+8.83%
(1D)No price chart data available for 1D timeframe.
Rating
30
-2.0 ptsFundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #793/1021 (Top 78%)
Key Statistics
Market Data
Market Cap $459.69M
1D Range
3.10 3.55
52W Range
0.94 4.75
Valuation (TTM)
PE -0.86
PB 44.49
EV/EBITDA -31.72
Valuation (NTM)
Forward PE N/A
Forward PEG 0.01
Price Target $0.00
Cash Flow
FCF Yield -3.0%
SBC Adj. FCF Yield -3.2%
SBC Impact -7.1%
Margins
Gross Margin 0.0%
Operating Margin 0.0%
FCF Margin N/A
Growth (CAGR)
Revenue 3Y | 5Y N/A |
N/A
Dil EPS 3Y | 5Y 79.2% |
29.0%
FCF 3Y | 5Y -7.5% |
2.2%
Returns
ROA -43.2%
ROE -206.8%
ROIC -43.8%
Financial Health
Net Cash
$30.6M
Current Ratio 92.76
Interest Coverage 0.00
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Indaptus Therapeutics, Inc. is a biotechnology company operating in the pre-clinical phase, dedicated to developing a range of immunotherapeutic products for the treatment of both cancer and viral inf...
Sector Healthcare
Industry Biotechnology
Employees 5
IPO Date Aug 4, 2015
Website indaptusrx.com
Fiscal Year January - December
Latest News
No news articles available yet.
Add to Watchlist
Select watchlists to add or remove INDP